These emerging medications , Semaglutide , represent a remarkable advancement in managing metabolic dysfunction and potentially related ailments . These drugs are classified as GLP-1 receptor agonists https://victorgvoj903066.webbuzzfeed.com/41889418/semaglutide-a-comprehensive-exploration-into-incretin-compounds